DE1917981A1 - Arzneimittel fuer die Behandlung von Erkrankungen der Virusaetiologie - Google Patents
Arzneimittel fuer die Behandlung von Erkrankungen der VirusaetiologieInfo
- Publication number
- DE1917981A1 DE1917981A1 DE19691917981 DE1917981A DE1917981A1 DE 1917981 A1 DE1917981 A1 DE 1917981A1 DE 19691917981 DE19691917981 DE 19691917981 DE 1917981 A DE1917981 A DE 1917981A DE 1917981 A1 DE1917981 A1 DE 1917981A1
- Authority
- DE
- Germany
- Prior art keywords
- treatment
- diseases
- viral etiology
- medicines
- drug
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000003814 drug Substances 0.000 title claims description 14
- 201000010099 disease Diseases 0.000 title claims description 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title claims description 8
- 230000003612 virological effect Effects 0.000 title claims description 8
- 229940079593 drug Drugs 0.000 title description 11
- 229940099259 vaseline Drugs 0.000 claims description 4
- 239000004480 active ingredient Substances 0.000 claims description 2
- 229940126601 medicinal product Drugs 0.000 claims description 2
- 239000003937 drug carrier Substances 0.000 claims 2
- 241000272184 Falconiformes Species 0.000 claims 1
- 239000013543 active substance Substances 0.000 claims 1
- 239000003883 ointment base Substances 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- OCOSYMCDPNAWPA-UHFFFAOYSA-N 2,4-dibromo-6-(3,5-dibromo-2,4-dihydroxyphenyl)benzene-1,3-diol Chemical compound OC1=C(Br)C(O)=C(Br)C=C1C1=CC(Br)=C(O)C(Br)=C1O OCOSYMCDPNAWPA-UHFFFAOYSA-N 0.000 description 9
- 239000002674 ointment Substances 0.000 description 9
- 208000007514 Herpes zoster Diseases 0.000 description 6
- 206010023332 keratitis Diseases 0.000 description 5
- 208000005100 Herpetic Keratitis Diseases 0.000 description 4
- 206010073938 Ophthalmic herpes simplex Diseases 0.000 description 4
- 241001122767 Theaceae Species 0.000 description 4
- 241000700605 Viruses Species 0.000 description 4
- 201000010884 herpes simplex virus keratitis Diseases 0.000 description 4
- 238000011084 recovery Methods 0.000 description 4
- 201000004681 Psoriasis Diseases 0.000 description 3
- 206010037898 Rash vesicular Diseases 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 241000701161 unidentified adenovirus Species 0.000 description 3
- 208000009889 Herpes Simplex Diseases 0.000 description 2
- 206010061217 Infestation Diseases 0.000 description 2
- 206010023644 Lacrimation increased Diseases 0.000 description 2
- 210000004087 cornea Anatomy 0.000 description 2
- 108010074605 gamma-Globulins Proteins 0.000 description 2
- 201000010666 keratoconjunctivitis Diseases 0.000 description 2
- 230000004317 lacrimation Effects 0.000 description 2
- 208000017520 skin disease Diseases 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 241001529453 unidentified herpesvirus Species 0.000 description 2
- 206010001257 Adenoviral conjunctivitis Diseases 0.000 description 1
- 206010006784 Burning sensation Diseases 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- 206010012468 Dermatitis herpetiformis Diseases 0.000 description 1
- 206010015958 Eye pain Diseases 0.000 description 1
- XQFRJNBWHJMXHO-RRKCRQDMSA-N IDUR Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(I)=C1 XQFRJNBWHJMXHO-RRKCRQDMSA-N 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 206010034960 Photophobia Diseases 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 201000007717 corneal ulcer Diseases 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 210000000744 eyelid Anatomy 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 229910052743 krypton Inorganic materials 0.000 description 1
- DNNSSWSSYDEUBZ-UHFFFAOYSA-N krypton atom Chemical compound [Kr] DNNSSWSSYDEUBZ-UHFFFAOYSA-N 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000003253 viricidal effect Effects 0.000 description 1
- 230000003313 weakening effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
- A61K31/055—Phenols the aromatic ring being substituted by halogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Virology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SU681233438A SU465815A1 (ru) | 1968-04-18 | 1968-04-18 | Лекарственное средство |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE1917981A1 true DE1917981A1 (de) | 1969-12-04 |
Family
ID=20442281
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE19691917981 Withdrawn DE1917981A1 (de) | 1968-04-18 | 1969-04-09 | Arzneimittel fuer die Behandlung von Erkrankungen der Virusaetiologie |
Country Status (4)
| Country | Link |
|---|---|
| DE (1) | DE1917981A1 (enrdf_load_stackoverflow) |
| FR (1) | FR2007474A1 (enrdf_load_stackoverflow) |
| GB (1) | GB1225584A (enrdf_load_stackoverflow) |
| SU (1) | SU465815A1 (enrdf_load_stackoverflow) |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL140732B (nl) * | 1965-05-04 | 1974-01-15 | Acf Chemiefarma Nv | Werkwijze voor het bereiden van geneesmiddelen met antiparasitaire werking en actieve bestanddelen daarvoor, alsmede de hierbij verkregen voortbrengselen. |
-
1968
- 1968-04-18 SU SU681233438A patent/SU465815A1/ru active
-
1969
- 1969-04-09 DE DE19691917981 patent/DE1917981A1/de not_active Withdrawn
- 1969-04-15 GB GB1225584D patent/GB1225584A/en not_active Expired
- 1969-04-18 FR FR6912119A patent/FR2007474A1/fr not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| FR2007474A1 (enrdf_load_stackoverflow) | 1970-01-09 |
| GB1225584A (enrdf_load_stackoverflow) | 1971-03-17 |
| SU465815A1 (ru) | 1987-03-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69632034T2 (de) | Pharmazeutische zubereitung zur topischen applikation enthaltend acyclovir und hydrokortison | |
| DE69829112T2 (de) | Butyrate Derivate zur Behandlung von Fibromyalgia und chronischem Müdigkeits-Syndrom | |
| DE60118859T2 (de) | Pharmazeutische Zusammensetzung enthaltend Trehalose zur ophthalmischen Verwendung | |
| Mahmoud et al. | Anti-inflammatory effects of tartar emetic and niridazole: suppression of schistosome egg granuloma | |
| DE3119051A1 (de) | Mittel zur behandlung der augen | |
| DE3780618T2 (de) | Verwendung von buspiron zur verbesserung des kurzzeitgedaechtnisses. | |
| DE69425246T2 (de) | Monoklonale antikoerper gegen lfa-1 zur herstellung eines arzneimittels zur vorbeugung der transplantatabstossung von organen | |
| DE69425826T2 (de) | Medikament zum schutz vor neurologischen schäden | |
| US4394381A (en) | Method for the relief of pain | |
| CH672987A5 (enrdf_load_stackoverflow) | ||
| Duke | Clinical experience with pimozide: emphasis on its use in postherpetic neuralgia | |
| EP0185210A2 (de) | Verwendung von Dipeptidderivaten für die Herstellung von Arzneimitteln zur Behandlung von an amyotropher Lateralsklerose Erkrankten | |
| DE69501359T2 (de) | Verwendung von Phosphatdiestern zur Behandlung von Erkrankungen der Retina | |
| DE2208787A1 (de) | Virusheilmittel | |
| DE69013431T2 (de) | Anthocyanidine zur Behandlung von Augenkrankheiten. | |
| DE2721014C2 (enrdf_load_stackoverflow) | ||
| DE69303305T2 (de) | Mittel zur Behandlung chronischer Ermüdungserscheinungen | |
| DE1917981A1 (de) | Arzneimittel fuer die Behandlung von Erkrankungen der Virusaetiologie | |
| DE3619426A1 (de) | Mittel zur erhoehung der widerstandskraft gegen erkaeltungskrankheiten bei patienten mit eingeschraenkter lungenfunktion | |
| EP0294538B1 (de) | Verwendung von Nigerizin zur Herstellung eines Mittels zur Behandlung von Virus-Erkrankungen | |
| DE1917981C (de) | Arzneimittel zur externalen Behandlung von Viruskrankheiten | |
| EP2803354B1 (de) | Kombination aus Polyacrylsäure und 2-Amino-2-methylpropanol zur Verwendung in der Behandlung von Herpesinfektionen | |
| DE2532017C2 (de) | Ophthalmisches Mittel zur topischen Verabreichung | |
| DE69904206T2 (de) | Verwendung von cetirizin zur vorbeugung von asthma eintritt | |
| DE3250068C2 (enrdf_load_stackoverflow) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| E77 | Valid patent as to the heymanns-index 1977 | ||
| EHJ | Ceased/non-payment of the annual fee |